Characterization of Novel Multiantigenic Vaccine Candidates with Pan-HLA Coverage against Mycobacterium tuberculosis …
TO DOWNLOAD
ImMucin™ A novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1 expressing tumors …
TO DOWNLOAD
Phase I/II study exploring ImMucin™ a pan-major histocompatibility complex, anti-MUC1 signal peptide vaccine, in multiple myeloma patients …
TO DOWNLOAD
Autoantibodies against the signal peptide domain of MUC1 in patients with multiple myeloma Implications …
TO DOWNLOAD
Cell Surface-Associated Anti-MUC1-Derived Signal Peptide Antibodies Implications for Cancer Diagnostics and Therapy …
TO DOWNLOAD
Signal peptides and trans-membrane regions are broadly immunogenic and have high CD8+ T cell epitope densities: Implications for vaccine development …
TO DOWNLOAD